The Lidocaine Hydrochloride Jelly, cataloged under National Stock Number 6505-01-268-3733, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Amphastar Pharmaceuticals, Inc.. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-268-3733 |
| Primary Part Number | 3012-SP |
| Item Name | Lidocaine Hydrochloride Jelly |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Amphastar Pharmaceuticals, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 5.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL INJECTOR UNIT |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Active Medicament Medicinal Strength | 2.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| 3012-SP PRIMARY | Amphastar Pharmaceuticals, Inc. (USA) |
| NDC76329-3012-05 PRIMARY | Amphastar Pharmaceuticals, Inc. (USA) |
| Reference | Meaning |
|---|---|
| URO-JET 5ML | 5/1 Secondary reference Amphastar Pharmaceuticals, Inc. |
NSN 6505-01-268-3733 is a Lidocaine Hydrochloride Jelly, manufactured by Amphastar Pharmaceuticals, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-268-3733 has 2 manufacturer part numbers on file: 3012-SP (Amphastar Pharmaceuticals, Inc.), NDC76329-3012-05 (Amphastar Pharmaceuticals, Inc.).
Key specifications for 3012-SP: Primary Container Content Quantity: 5.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL INJECTOR UNIT; Special Features: VIAL INJECTOR UNIT, STORE AT 15 TO 30 C (59 TO 86 F), EACH PACKAGE CONTAINS ONE SINGLE USE VIAL AND A VIAL INJECTOR.. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.